Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (231-240 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastomaJan Drappatz, Andrew D Norden, Eric T Wong, et al.
Acta Neuropathologica|December 3, 2016
Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor TaxonomyDavid N Louis, Ken Aldape, Daniel J Brat, et al.
Cancer|January 15, 2015
Proton therapy for low-grade gliomas: Results from a prospective trialHelen A Shih, Janet C Sherman, Lisa B Nachtigall, et al.
Brain Pathology (Zurich, Switzerland)|December 21, 2016
cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classificationDavid N Louis, Ken Aldape, Daniel J Brat, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2022
Factors associated with psychological distress in caregivers of patients with malignant gliomasDeborah A Forst, Alyx F Podgurski, Kit M Quain, et al.
Journal of Neuro-Oncology|November 18, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastomaJayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, et al.
Neuro-Oncology|April 25, 2007
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adultsSantosh Kesari, David Schiff, Lisa Doherty, et al.
Journal of Neuro-Oncology|October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Drappatz, E Q Lee, S Hammond, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2008
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiformeJan Drappatz, Eric T Wong, David Schiff, et al.
Blood Advances|April 10, 2024
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, et al.
Pageof 33

Showing results (231-240 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastomaJan Drappatz, Andrew D Norden, Eric T Wong, et al.
Acta Neuropathologica|December 3, 2016
Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor TaxonomyDavid N Louis, Ken Aldape, Daniel J Brat, et al.
Cancer|January 15, 2015
Proton therapy for low-grade gliomas: Results from a prospective trialHelen A Shih, Janet C Sherman, Lisa B Nachtigall, et al.
Brain Pathology (Zurich, Switzerland)|December 21, 2016
cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classificationDavid N Louis, Ken Aldape, Daniel J Brat, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2022
Factors associated with psychological distress in caregivers of patients with malignant gliomasDeborah A Forst, Alyx F Podgurski, Kit M Quain, et al.
Journal of Neuro-Oncology|November 18, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastomaJayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, et al.
Neuro-Oncology|April 25, 2007
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adultsSantosh Kesari, David Schiff, Lisa Doherty, et al.
Journal of Neuro-Oncology|October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade gliomaJ Drappatz, E Q Lee, S Hammond, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2008
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiformeJan Drappatz, Eric T Wong, David Schiff, et al.
Blood Advances|April 10, 2024
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, et al.
Pageof 33